NeuroMetrix, Inc., a medical device company focused on the design, development and sale of proprietary products used to diagnose neuropathies, or diseases of the nerves, announced today the financial results for the three month and twelve month periods ended December 31, 2005. Total revenues for the three months ended December 31, 2005, the Company's fourth quarter, were $10.3 million, compared with $5.8 million for the fourth quarter of 2004, representing an increase of 79%.
Genetic Engineering News